|
AIDSinfo E-News: Offering HIV/AIDS Research, Clinical Trials, Prevention, and Treatment Information. |
|
AIDSinfo At-a-Glance Issue No. 18May 04, 2006
AIDSinfo.nih.gov is pleased
to provide you with a weekly update of highlights about what has happened
in the world of HIV/AIDS treatment, prevention, and research. We hope you
find this encapsulated view of HIV/AIDS news useful.
The Guidelines for the Use of
Antiretroviral Agents in HIV-1-Infected Adults and Adolescents has
been revised to include up-to-date treatment information, including new
recommendations for resistance testing, treatment interruption, and
HBV/HIV co-infection. Tables have been revised to include up-to-date
information about drug interactions and about the lopinavir/ritonavir
200/50 mg tablet formulation. Changes to the document are summarized in
the “What’s New in the Document?” section, and all changes to the document
are highlighted throughout the text.
The
updated guidelines document is available in the ADULT
GUIDELINES section of the GUIDELINES page on the AIDSinfo
Web site. You can order hard copies of the guidelines or request them by
e-mail to:
.Aidsinfowebmaster.
Your
feedback is important!
The Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents would like to hear your feedback on this latest revision of the "Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents." Please send your comments with the subject line: Adult Guidelines Comments to: AIDSinfoWebmaster@aidsinfo.nih.gov by May 22, 2005. Please send comments or suggestions to ContactUs@aidsinfo.nih.gov
ISSN 1558-3228 |
|
|
|
You are currently subscribed to %%list.name%% as:
%%emailaddr%% Subscribe to AIDSinfo list serv here. |
|
Contact AIDSinfo Click on the Live Help button on the AIDSinfo home page
and communicate with the staff in “real time.” |